These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 15228236

  • 21. Campath-1H as rescue therapy for the treatment of acute rejection in kidney transplant patients.
    Csapo Z, Benavides-Viveros C, Podder H, Pollard V, Kahan BD.
    Transplant Proc; 2005 Jun; 37(5):2032-6. PubMed ID: 15964331
    [Abstract] [Full Text] [Related]

  • 22. Pharmacokinetics of CAMPATH-1H in BMT patients.
    Rebello P, Cwynarski K, Varughese M, Eades A, Apperley JF, Hale G.
    Cytotherapy; 2001 Jun; 3(4):261-7. PubMed ID: 12171714
    [Abstract] [Full Text] [Related]

  • 23. Correlation between human leukocyte antigen antibody production and serum creatinine in patients receiving sirolimus monotherapy after Campath-1H induction.
    Cai J, Terasaki PI, Bloom DD, Torrealba JR, Friedl A, Sollinger HW, Knechtle SJ.
    Transplantation; 2004 Sep 27; 78(6):919-24. PubMed ID: 15385814
    [Abstract] [Full Text] [Related]

  • 24. Alemtuzumab induction therapy in highly sensitized kidney transplant recipients.
    Lü TM, Yang SL, Wu WZ, Tan JM.
    Chin Med J (Engl); 2011 Mar 27; 124(5):664-8. PubMed ID: 21518554
    [Abstract] [Full Text] [Related]

  • 25. Alemtuzumab induction and prednisone-free maintenance immunotherapy in kidney transplantation: comparison with basiliximab induction--long-term results.
    Kaufman DB, Leventhal JR, Axelrod D, Gallon LG, Parker MA, Stuart FP.
    Am J Transplant; 2005 Oct 27; 5(10):2539-48. PubMed ID: 16162205
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Evaluation of late immunologic parameters among renal transplant recipients induced with Campath-1H.
    Alba A, Morales J, Fierro A, Zehnder C, Cao C, Orozco R, Herzog C, Calabrán L, Contreras L, Buckel E.
    Transplant Proc; 2010 Oct 27; 42(1):253-6. PubMed ID: 20172322
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The role of alemtuzumab in facilitating maintenance immunosuppression minimization following solid organ transplantation.
    Agarwal A, Shen LY, Kirk AD.
    Transpl Immunol; 2008 Nov 27; 20(1-2):6-11. PubMed ID: 18824230
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. A randomized trial of alemtuzumab vs. anti-thymocyte globulin induction in renal and pancreas transplantation.
    Farney A, Sundberg A, Moore P, Hartmann E, Rogers J, Doares W, Jarrett A, Adams P, Stratta R.
    Clin Transplant; 2008 Nov 27; 22(1):41-9. PubMed ID: 18217904
    [Abstract] [Full Text] [Related]

  • 34. Alemtuzumab induction and steroid-free maintenance immunosuppression in pancreas transplantation.
    Muthusamy AS, Vaidya AC, Sinha S, Roy D, Elker DE, Friend PJ.
    Am J Transplant; 2008 Oct 27; 8(10):2126-31. PubMed ID: 18828772
    [Abstract] [Full Text] [Related]

  • 35. Effective therapy for a murine model of adult T-cell leukemia with the humanized anti-CD52 monoclonal antibody, Campath-1H.
    Zhang Z, Zhang M, Goldman CK, Ravetch JV, Waldmann TA.
    Cancer Res; 2003 Oct 01; 63(19):6453-7. PubMed ID: 14559836
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Prope tolerance with induction using Campath 1H and low-dose cyclosporin monotherapy in 31 cadaveric renal allograft recipients.
    Calne R, Moffatt SD, Friend PJ, Jamieson NV, Bradley JA, Hale G, Firth J, Bradley J, Smith KG, Waldmann H.
    Nihon Geka Gakkai Zasshi; 2000 Mar 01; 101(3):301-6. PubMed ID: 10773997
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Campath-1H immunosuppressive therapy reduces incidence and intensity of acute rejection in intestinal and multivisceral transplantation.
    Garcia M, Weppler D, Mittal N, Nishida S, Kato T, Tzakis A, Ruiz P.
    Transplant Proc; 2004 Mar 01; 36(2):323-4. PubMed ID: 15050146
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.